Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Ally Financial
ALLY
5
Louisiana-Pacific
LPX
JP Stock MarketDetailed Quotes
4893 Noile-Immune Biotech
- 143
- +1+0.70%
20min DelayNot Open May 12 15:30 JST
6.19BMarket Cap-6.42P/E (Static)
145High140Low131.60KVolume144Open142Pre Close18.79MTurnover35352wk High0.87%Turnover Ratio43.30MShares12052wk Low-22.28EPS TTM2.16BFloat Cap775Historical HighLossP/E (Static)15.12MShs Float120Historical Low-22.28EPS LYR3.52%Amplitude--Dividend TTM1.31P/B100Lot Size--Div YieldTTM
Noile-Immune Biotech News
Noile-Immune Biotech: Summary of financial results for the 1st quarter of the fiscal year ending 2025/12 [Japanese GAAP] (unconsolidated)
Noile-Immune Biotech: Extraordinary Report
Noile-Immune Biotech: Confirmation letter
Noile-Immune Biotech: Financial Report - 10th Term (2024/01/01 - 2024/12/31)
Noile-Immune Biotech: Summary of financial results for the fiscal year ending 2024/12 [Japanese GAAP] (unconsolidated)
Noile-Immune Biotech: Notice regarding publication of earnings forecasts
Noile-Immune Biotech: Summary of financial results for the 3rd quarter of the fiscal year ending 2024/12 [Japanese GAAP] (unconsolidated)
Noile-Immune Biotech: Correction Confirmation Form
Noile-Immune Biotech: Revised Semi-Annual Report - Term 10 (2024/01/01 to 2024/12/31)
Noile-Immune Biotech: Semi-Annual Report - Term 10 (2024/01/01 - 2024/12/31)
Noile-Immune Biotech: Confirmatory letter.
Noile-Immune Biotech: 2nd quarter (interim) financial report for the fiscal year ending December 2024 [Japan Standard] (non-consolidated)
Noile-Immune Biotech: Confirmation letter
Noile-Immune Biotech: Quarterly Report - 10th Quarter 1st Quarter (2024/01/01 - 2024/03/31)
Noile-Immune Biotech: Summary of financial results for the 1st quarter of the fiscal year ending 2024/12 [Japanese GAAP] (unconsolidated)
Neurimune Biotech: Extraordinary Report
Neurimune Biotech: Confirmation
Noile-Immune Biotech: Financial Report - Term 9 (2023/01/01 - 2023/12/31)
Noile-Immune Biotech: Summary of financial results for the fiscal year ending 2023/12 [Japanese GAAP] (unconsolidated)
Noile-Immune Biotech: Notice regarding revisions to full-year earnings forecasts
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting